July 14- Several multi-billion dollar deals and bids have made 2014 a busy year for healthcare acquisitions, despite Pfizer pulling its $118 billion offer for AstraZeneca.
*Alcoa tops expectations; shares up in premarket. *Citigroup may pay $7 billion to resolve probe: source. *Alcoa Inc rose 2 percent to $15.14 in premarket trading a day after reporting second-quarter adjusted earnings and revenue that topped expectations.
WASHINGTON, June 12- An advisory committee to the U.S. Food and Drug Administration recommended on Thursday that the agency not require large cardiovascular safety trials for a class of drugs used to treat opioid-induced chronic constipation.
The FDA nonetheless approved it for short-term use because other trials did not show a similar so-called cardiovascular safety signal.
Some of the names on the move ahead of the open.
A long position in Salix Pharma looked like a hot trade but all it did was burn Joe Terranova. So what does he have to say about this stock now?
With small-cap stocks thus far outperforming their large-cap counterparts through the recovery, do companies with smaller market share still have room to the upside? Bill McVail, lead manager of Turner Small Cap Growth Fund, and Kent Croft, chief investment officer of Croft Funds, offered their views and stock picks to CNBC.
Cramer makes the call on viewers' favorite stocks.
Stocks moved into positive territory Monday afternoon as tech, bank and drug stocks gained and volatility waned.
Stocks pared their losses Monday as President Obama's speech on financial reform had little impact on the market.
Stocks declined Monday as investors worried about a trade dispute between the US and China and reflected on the one-year anniversary of the Lehman Brothers collapse.
Investors were in a reflective mood Monday as the anniversary of the collapse of Wall Street titan Lehman Brothers brought back memories of the financial crisis and raised fresh doubts over the recovery.
Good morning all. Parker Robinson and James Kraber remain in the top two positions, with James holding the 2nd and 4th positions, and remember Deborah Taft? She made a strong move back into third place. Parker's portfolio value stands at $2,796,103.27, up $3,000 from Monday on bonus bucks.